| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/04/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 1,259 shares
@ $232.9592, valued at
$293.3k
Sold 2,141 shares
@ $233.529, valued at
$500k
Sold 600 shares
@ $236.8764, valued at
$142.1k
Sold 300 shares
@ $238.3933, valued at
$71.5k
Sold 400 shares
@ $239.9875, valued at
$96k
Sold 1,000 shares
@ $241.611, valued at
$241.6k
Sold 300 shares
@ $243.13, valued at
$72.9k
Exercised 6,000 options
@ $117.76, valued at
$706.6k
|
|
| 08/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/02/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/02/2023 |
8-K
| Quarterly results |
| 08/02/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/24/2023 |
8-K
| Quarterly results |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
8-K/A
| Quarterly results |
| 07/10/2023 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 10% stake in UNITED THERAPEUTICS Corp |
| 07/07/2023 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Exercised 880 restricted stock units
@ $0 |
|
| 07/07/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 3,913 shares
@ $214.5786, valued at
$839.6k
Sold 1,187 shares
@ $215.5178, valued at
$255.8k
Sold 700 shares
@ $217.2366, valued at
$152.1k
Sold 200 shares
@ $218.17, valued at
$43.6k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 07/07/2023 |
4
| Thompson Tommy G (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Exercised 880 restricted stock units
@ $0 |
|
| 07/07/2023 |
4
| Olian Judy D. (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Exercised 1,750 restricted stock units
@ $0 |
|
| 07/07/2023 |
4
| Mesa Nilda (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Exercised 880 restricted stock units
@ $0 |
|
| 07/07/2023 |
4
| KURZWEIL RAY (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Exercised 880 restricted stock units
@ $0 |
|
| 07/07/2023 |
4
| Klein Katherine J (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Exercised 880 restricted stock units
@ $0 |
|
| 07/07/2023 |
4
| DWEK RAYMOND (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Exercised 1,750 restricted stock units
@ $0 |
|
|